Articles tagged with “pharma-ai-governance”

AI Governance in Biotech: Council Charter and Decision Rights

A 2026 analyst guide to AI governance in biotech: council charter templates, decision rights (RACI), FDA/EMA principles, EU AI Act deadlines, and six company case studies.

40 min read

6/30/2026

ai governance biotech biotech ai steering committee ai council charter life sciences ai decision rights framework pharma ai governance chief ai officer pharma eu ai act pharma fda ai guidance

How to Build an AI Center of Excellence in Biotech (2026)

A 2026 analyst guide to building an AI Center of Excellence in biotech: hub-spoke-hybrid models, FDA/EMA/NIST governance, staffing budgets from $2M to $200M, and named cases from Sanofi, Merck, Novartis, AstraZeneca, and GSK.

45 min read

6/26/2026

ai center of excellence biotech ai strategy pharma ai governance ai coe framework hub and spoke model chief ai officer life sciences ai fda ai guidance ai operating model pharma digital transformation